Izuma Nakayama - Concepedia

Author

Izuma Nakayama

Japanese Foundation For Cancer Research ORCID

Also Known As

I Nakayama, I. Nakayama, IZUMA NAKAYAMA, Ichiro NAKAYAMA, Izuma Nakayama, Masuko Katoh, Yohann Loriot

210

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Japanese Foundation For Cancer Research The Cancer Institute Hospital National Cancer Center Hospital East Keio University Tohoku University

About

Izuma Nakayama is an author at Japanese Foundation For Cancer Research specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	300
2	Gastroenterology	7	7	163
3	Health Sciences	2	2	60
4	Hepatology	2	2	22
5	Immunology	2	2	120

Izuma Nakayama

Publications

889

Citations

H-Index

Page 1

	Year	Citations
Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer Takeru Wakatsuki, Noriko Yamamoto, Takeshi Sano, Journal of Gastroenterology	2018	100
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer Kohei Shitara, Tania Fleitas, Hisato Kawakami, ESMO Open	2024	73
Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival Yumiko Ota, Daisuke Takahari, Takeshi Suzuki, Cancer Chemotherapy and Pharmacology Gastrointestinal OncologyMedicineImmunologyGastroenterologyImmune Checkpoint Inhibitor	2020	71
Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer Shusuke Yagi, Takeru Wakatsuki, Noriko Yamamoto, Gastric Cancer	2018	70
Enrichment of <i>CLDN18</i>‐<i>ARHGAP</i> fusion gene in gastric cancers in young adults Izuma Nakayama, Eiji Shinozaki, Seiji Sakata, Cancer Science	2019	62
Papillary Cystic Tumor of the Pancreas: an Immunohistochemical and Ultra-structural Study of 14 Patients Keisuke Yamaguchi, T Miyagahara, M Tsuneyoshi, Japanese Journal of Clinical Oncology Papillary Cystic TumorsSurgical OncologyPancreatic CancerPancreatic Fluid CollectionSurgical Pathology	1989	49
Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma Takeshi Suzuki, Akihiko Okamura, Masayuki Watanabe, Annals of Surgical Oncology Surgical OncologyNeoadjuvant ChemoradiotherapyEsophageal CancerCisplatin Plus FluorouracilMedicine	2019	37
Clinical Impact of Primary Tumor Location and<i>RAS, BRAF</i>V600E, and<i>PIK3CA</i>Mutations on Epidermal Growth Factor Receptor Inhibitor Efficacy as Third-line Chemotherapy for Metastatic Colorectal Cancer Taro Sato, Hiroki Osumi, Eiji Shinozaki, Anticancer Research	2021	29
Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients Izuma Nakayama, Eiji Shinozaki, Tomohiro Matsushima, BMC Cancer	2017	24
Associations between early tumor shrinkage and depth of response and clinical outcomes in patients treated with 1st-line chemotherapy for advanced gastric cancer Hiroki Osumi, Daisuke Takahari, Eiji Shinozaki, Gastric Cancer Surgical OncologyGastrointestinal OncologyEarly Tumor ShrinkageAdvanced Gastric CancerMedicine	2017	23

Page 1